Human cytosolic leucyl-tRNA synthetase is one component of a macromolecular aminoacyl-tRNA synthetase complex. This is unlike prokaryotic and lower eukaryotic LeuRSs that exist as free soluble enzymes. There is little known about it, since the purified enzyme has been unavailable. Herein, human cytosolic leucyl-tRNA synthetase was heterologously expressed in a baculovirus system and purified to homogeneity. The molecular mass (135 kDa) of the enzyme is close to the theoretical value derived from its cDNA. The kinetic constants of the enzyme for ATP, leucine, and tRNA Leu in the ATP-PP i exchange and tRNA leucylation reactions were determined, and the results showed that it is quite active as a free enzyme. Human cytosolic leucyl-tRNA synthetase expressed in human 293 T cells localizes predominantly to the cytosol. Additionally, it is found to have a long C-terminal extension that is absent from bacterial and yeast LeuRSs. A C-terminal 89-amino acid truncated human cytosolic leucyl-tRNA synthetase was constructed and purified, and the catalytic activities, thermal stability, and subcellular location were found to be almost identical to native enzyme. In vivo and in vitro experiments, however, show that the C-terminal extension of human cytosolic leucyl-tRNA synthetase is indispensable for its interaction with the N-terminal of human cytosolic arginyl-tRNA synthetase in the macromolecular complex. Our results also indicate that the two molecules interact with each other only through their appended domains.
Aminoacyl-tRNA synthetases (aaRSs) 3 catalyze specific esterification of an amino acid with the 3Ј-terminal hydroxyl group of its cognate tRNA (1, 2) . The reaction can be separated into two steps: 1) the ATP-PP i exchange for amino acid activation and 2) aminoacylation of tRNA (1, 2) . Based on structural features, aaRSs have been divided into two classes, I and II; there are three subclasses in each class (2) .
In higher eukaryotes, from flies to humans, a macromolecular complex has been discovered consisting of 11 polypeptides and containing activities of nine aaRSs: bifunctional glutamylprolyl-, isoleucyl-, leucyl-, methionyl-, glutaminyl-, lysyl-, arginyl-, and aspartyl-tRNA synthetases and three nonsynthetase components, p18, p38, and p43 (3, 4) . The structure of the aaRS complex has been analyzed through various approaches. Electron microscopy has revealed that the complex has a "cup" or elongated U-shaped structure (5) . Chaotropic salts, detergents (6, 7) , and hydrophobic chromatography (8 -10) partially dissociate the components of the complex, suggesting that hydrophobic interactions between the enzymes are responsible for the assembly of the complex (11) . Interactions between adjacent aaRSs have been determined with chemical cross-linking (12, 13) . Additionally, genetic approaches such as the yeast two-hybrid approach have been applied to detect the interactions between the components of the complex (14) . The function of the terminal extensions of the aaRSs in the complex assembly has also been tested (15) . However, the whole structure and the interactions among the components of the complex have not been clearly elucidated until now. Arginyl-tRNA synthetase is a particular synthetase in that it exists in two forms within mammalian cells. The high molecular weight form is a part of the multi-tRNA synthetase complex, whereas the low molecular weight form, which is short of the N-terminal extension, is a free enzyme (16) . It has been suggested that the N-terminal extension is responsible for the enzyme association with the complex (17) . Chemical cross-linking and yeast two-hybrid assays have proven that ArgRS interacts with GluProRS, IleRS, LysRS, GlnRS, and p43 (13, 14, 18) . The N terminus of ArgRS shows interaction with the repeated motif of GluProRS (19) , the terminal extensions of LeuRS, LysRS, GlnRS, and MetRS (15) . The interaction between ArgRS and p43 has been extensively investigated (20, 21) .
Human cytosolic leucyl-tRNA synthetase (hcLeuRS; EC 6.1.1.4) has been identified as a component of the human aaRS multienzyme complex (3, 4) , but little information about it has been previously obtained. Recently, a cDNA isolated from a human fetal brain has been suggested to be that of hcLeuRS (hcleus) (22) . When hcleus was entered into a BLAST search against the human genome data base, 31 exons of the gene were found located on the chromosome 5q32 region (22) . According to cDNA analysis, hcLeuRS belongs to the Ia aaRSs, a subclass characterized by the two motifs HIGH and MSKS (2) . Composed of 1176 amino acid residues, hcLeuRS has a total molecular mass of 134.4 kDa. hcLeuRS is 13.1% identical to Escherichia coli and 10.8% identical to human mitochondrial LeuRS (hmLeuRS). Human and Saccharomyces cerevisiae, Drosophila melanogaster, and Mus musculus cytosolic LeuRSs share 39.7, 58.3, and 90.0% identical residues, respectively (data not shown). hcLeuRS has been suggested to interact with LysRS, ArgRS, and IleRS (13, 15) by chemical cross-linking and yeast two-hybrid methods. Like many other mammalian and human aaRSs, hcLeuRS has a long C-terminal extension, unlike bacterial and yeast enzymes (Fig. 1 ). Long extensions in higher eukaryotes have been postulated to be responsible for the assembly of the aaRS complex, since their appearance accompanies the complex formation.
Herein, hcleus and ⌬Chcleus, encoding the full-length and the C-terminal truncated hcLeuRS fused with a DNA sequence encoding a C-terminal His tag, were cloned into a baculovirus vector and used to infect Trichoplusia ni BTI-Tn-5B1-4 insect cells (Tn5). His-tagged hcLeuRS and ⌬ChcLeuRS from the cytosol were purified with Ni 2ϩ -NTA column chromatography, and their catalytic kinetic constants and thermal stability were determined. Additionally, we determined the kinetic constants of hcArgRS and ⌬NhcArgRS, the subcellular location of hcLeuRS, ⌬ChcLeuRS, hcArgRS, and ⌬NhcArgRS and proved that the C-terminal extension of hcLeuRS is able to interact with the N terminus of human cytosolic ArgRS (hcArgRS). The role of this specific interaction in the complex assembly is discussed.
EXPERIMENTAL PROCEDURES
Chemicals, Plasmids, and Cell Lines-All chemicals, unless otherwise noted, and the monoclonal anti-FLAG M2 antibody were purchased from Sigma. Anti-GFP antibody was purchased from Roche Applied Science. The enzymes used in DNA manipulation were obtained from New England Biolabs Inc. (Canada). [ 14 C]Leucine (300 -400 mCi/ mmol) and glutathione-Sepharose 4B were purchased from Amersham Biosciences. [ 32 P]tetrasodium pyrophosphate was obtained from PerkinElmer Life Sciences. GF/C filters were from Whatman Co.
(Germany). Ni 2ϩ -NTA Superflow was purchased from Qiagen Inc. (Germany). The Bac-to-Bac baculovirus expression system, pCDNA3, pEGFP-N2, and recombinant Protein G-agarose were purchased from Invitrogen. The plasmid pFastBac1 of the Bac-to-Bac baculovirus system was modified into pFastBac1H in order to add an Ala 3 -His 6 tag at the C terminus of the recombinant protein (23) . Calf liver tRNA and pET-22b(ϩ) were purchased from Novagen (EMD Biosciences, Inc., Germany). Immobilon P membrane was purchased from Millipore Corp. The SuperSignal West Pico trial kit was obtained from Pierce. All oligonucleotides for amplifying DNA fragments were synthesized by Bioasia Co. (Shanghai, China) and shown in TABLE ONE.
Gene Cloning, Expression, and Purification of hcLeuRS and ⌬ChcLeuRS in Bac-to-Bac Baculovirus System-The cDNA clonefj01313 containing hcleus was a gift from the Kazusa DNA Research Institute (Chiba, Japan) (22) . Three primers were designed for inserting hcleus (encoding full-length hcLeuRS) and ⌬Chcleus (encoding C-terminal 89-amino acid truncated hcLeuRS) into the SalI and NotI sites of pFastBac1H. With primers P1-P2 and P1-P3, DNA fragments containing hcleus and ⌬Chcleus were amplified by PCR from the fj01313 clone, digested by SalI and NotI, and inserted into identical sites in pFastBac1H. The obtained recombinant plasmids pFastBac1H-hcleus and pFastBac1H-⌬Chcleus were confirmed with DNA sequencing. For pFastBac1H-hcleus and pFastBac1H-⌬Chcleus, recombinant bacmids containing hcleus and ⌬Chcleus were obtained according to the instruction manual of the Bac-to-Bac baculovirus system. Then recombinant bacmids were used to separately transfect Tn5 insect cells for the expression of the genes encoding hcLeuRS and ⌬ChcLeuRS with a C-terminal Ala 3 -His 6 tag. After 3 days, Tn5 insect cells were harvested and washed twice with phosphate-buffered saline. Fractionation of sub- cellular cytosol/mitochondria was carried out as described (23) (24) (25) . Cytosol from the two cultures was further centrifuged at 150,000 ϫ g for 30 min. Supernatant of the cytosol was then loaded onto a Ni 2ϩ -NTA column (Qiagen GmbH, Germany) in order to isolate the His-tagged hcLeuRS and ⌬ChcLeuRS, per the manufacturer's instructions. All steps of fractionation and purification were carried out at 4°C.
Cloning, Expression, and Purification of hcArgRS and ⌬NhcArgRS-The plasmid (catalog number 97002RG) containing full-length cDNA of human liver cytoplasmic ArgRS was obtained from Invitrogen. With primers P4-P5 and P6-P5, the genes hcargs (encoding full-length hcArgRS) and ⌬Nhcargs (encoding N-terminal 72-amino acid truncated hcArgRS) were amplified from the plasmid, respectively. After digestion with NdeI and BamHI, the two generated DNA fragments were inserted into the corresponding sites of pET-15b to obtain pEThcargs and pET-⌬Nhcargs. E. coli BL21-CodonPlus (DE3)-RIL was transformed with the two plasmids, respectively, to produce hcArgRS and the N-terminal 72-amino acid truncated enzyme ⌬NhcArgRS. Colonies were grown at 25°C to achieve A 600 ϭ 0.6 in 1 liter of LB with 100 g/ml of ampicillin and 60 g/ml of chloramphenicol and were induced by adding isopropyl-1-thio-␤-D-galactopyranoside to 200 M, phenylmethylsulfonyl fluoride to 0.1 mM and glucose to 0.04% (w/v). After a 4-h induction, the cells were harvested and suspended in buffer A (10 mM imidazole, 300 mM NaCl, 10% glycerol, 20 mM, ␤-mercaptoethanol, 0.5 mM phenylmethylsulfonyl fluoride, 50 mM Na 2 HPO 4 , pH 8.0). After sonication and centrifugation, the supernatant was gently mixed with 1.5 ml of Ni 2ϩ -NTA Superflow resin for 30 min. The mixture was loaded on a minicolumn for gravity flow chromatography. The resin was washed with 15 ml of buffer B (except for 20 mM imodazole, other components were as for buffer A) to remove nonspecific binding contaminants. Then the enzyme was eluted with 20 ml of buffer C (again except for 250 mM imidazole, other components were as for buffer A). The eluted His 6 -hcArgRS or ⌬NhcArgRS fractions were pooled and dialyzed against 2 liters of buffer D (20 mM potassium phosphate buffer, pH 7.5), concentrated using a Centricon device (50 -200 l), gently mixed with an equal volume of glycerol, and stored at Ϫ20°C. All steps of the purification were carried out at 4°C.
Human Cytosolic tRNA Leu Leu or hctRNA Arg gene was constructed by insertion of the corresponding gene into pUC19. After linearization of plasmids with MvaI and FokI, separately, transcription was performed according to the instruction of RiboMAX large scale RNA production system-T7 (Promega Corp.). Transcripts were purified by 12% (w/v) denaturing PAGE, annealed by incubation for 5 min in 5 mM MgCl 2 at 80°C, and then cooled slowly to 20°C.
Enzymatic Kinetic Assays-The activity and kinetic constants in the ATP-PP i exchange or leucylation of the tRNA Leu reaction were determined at 37°C as described in a previous report (23) . Prior to the determination of substrate kinetic constants, the pH value and magnesium ion concentration were optimized for hcLeuRS activity to 7.6 and 2 mM. For determination of the ATP-PP i exchange, the reaction mixture contained 4 In the determination of kinetic constants, the concentration of leucine, ATP, calf liver tRNA Leu , or transcripts of hctRNA Leu was varied while the other components were held at the concentration corresponding to the reaction mixture. Reactions were initiated with the addition of 25 nM hcLeuRS and ⌬ChcLeuRS, respectively.
The activity and kinetic constants of hcArgRS and ⌬NhcArgRS were determined at 37°C. For determination of the ATP-PP i exchange, the Arg . In the determination of kinetic constants, the concentration of arginine, ATP, or calf liver tRNA Arg was varied while the other components were held at the concentration corresponding to the reaction mixture. Reactions were initiated with the addition of 5 nM hcArgRS and ⌬NhcArgRS, respectively.
Thermal Stability of hcLeuRS and ⌬ChcLeuRS-40 g/ml hcLeuRS and ⌬ChcLeuRS, in 5 mM potassium phosphate buffer (pH 7.6) containing 400 g/ml bovine serum albumin, 5% glycerol, and 2 mM dithiothreitol, were incubated at various temperatures for 10 min. Aminoacylation activity was then assayed at 37°C after dilution with 5 mM potassium phosphate buffer, pH 7.6.
Expression of Enhanced Green Fluorescence Protein (EGFP)-tagged hcLeuRS, ⌬ChcLeuRS, hcArgRS, and ⌬NhcArgRS in Human 293 T Cells and Confocal Fluorescence Microscopy-The hcleus, ⌬Chcleus, hcargs,
and ⌬Nhcargs DNA was amplified by PCR with four pairs of primers, P7-P8, P7-P9, P10-P11, and P11-P12, digested with XhoI and BamHI, and inserted into the gap of the XhoI and BamHI sites in pEGFP-N2 in order to obtain pEGFP-N2-hcleus, pEGFP-N2-⌬Chcleus, pEGFP-N2-hcargs, and pEGFP-N2-⌬Nhc args. In 293 T cells, pEGFP-N2-hcleus, pEGFP-N2-⌬Chcleus, pEGFP-N2-hcargs, and pEGFP-N2-⌬Nhcargs produce hcLeuRS, ⌬ChcLeuRS, hcArgRS, and ⌬NhcArgRS fused with EGFP at their C terminus. The 293 T cells were seeded on coverslips in 35-mm dishes. At 50% confluence, 293 T cells were transfected with 1 g of plasmid using SuperFect Transfection Reagent (Qiagen GmbH, Germany) per manufacturer's instructions. Transfected cells were continuously incubated for 48 h at 37°C. Nuclei were stained with 5 g/ml 4Ј,6-diamidino-2-phenylindole per the manufacturer's recommendation. Scanning confocal laser microscopy was performed using the BioRad radiance 2000 confocal microscope system and a ϫ64 oil immersion objective. Fluorescence images were captured using excitation (488 nm) and emission (515 nm) wavelengths for EGFP and excitation (360 nm) and emission (480 nm) for 4Ј,6-diamidino-2-phenylindole.
Plasmid Construction and Antibody Preparation for Immunoprecipitation-Two primers were designed for inserting hcleus and ⌬Chcleus with Flag tag DYKDDDK into pCDNA3. With the two pairs of P1-P15 and P1-P16, DNA fragments containing hcleus and ⌬Chcleus with FLAG tag sequence were amplified by PCR from pFastBac1H-hcleus, digested with SalI and NotI, and separately inserted into identical sites in pFastBac1H. The fragment between BamHI and NotI was then inserted into corresponding sites in pCDNA3. Primers P13 and P14 were designed to insert Chcleus (encoding the C-terminal 89 amino acids of hcLeuRS) into pEGFP-N2. Recombinant plasmids pCDNA3-hcleus-flag, pCDNA3-⌬Chcleus-flag, and pEGFP-N2-Chcleus were confirmed with DNA sequencing. To determine the interaction between hcLeuRS and hcArgRS, the hcArgRS and ⌬NhcArgRS were constructed and purified as described above. Anti-ArgRS polyclonal antibody was raised against ⌬NhcArgRS in hens by the Shenglongda Group Co. (China).
Cell Culture, DNA Transfection, and Immunoprecipitation-Human 293 T cells were cultured in Dulbecco's modified Eagle's medium supplemented with 10% fetal bovine serum in a 5% CO 2 incubator. Transfection of 293 T cells was performed with 5 g of pCDNA3-hcleus-flag, pCDNA3-⌬Chcleus-flag, pEGFP-N2 and pEGFP-N2-Chcleus using Superfectamine 2000 (Invitrogen), according to the manufacturer's protocol. Forty-eight hours after transfection, cells were washed twice with cold phosphate-buffered saline, lysed with lysis buffer (20 mM HEPES, pH 7.5, 150 mM NaCl, 0.2 mM EDTA, 10% glycerol, 1% Nonidet P-40, 1 mM NaF, 1 mM Na 3 VO 4 ) and complete protease inhibitor mixture (Roche Applied Science) for 15 min, and centrifuged at 12,000 rpm for 15 min. Lysates were incubated with monoclonal anti-FLAG M2 antibody and anti-GFP antibody, respectively, and then incubated with recombinant Protein G-agarose overnight. Immunoprecipitated samples were washed five times with lysis buffer (Nonidet P-40 adjusted to 0.1%) and then eluted from recombinant Protein G-agarose by boiling in 1ϫ SDS loading buffer.
Electrophoresis and Western Blot (WB)-Proteins were separated using SDS-PAGE and transferred to Immobilon P membrane. The membrane was blocked using 5% nonfat dry milk in phosphate-buffered saline supplemented with 0.05% Tween 20 and then immunoblotted with anti-ArgRS antibody and horseradish peroxidase-conjugated secondary antibody. Results were visualized using the SuperSignal West Pico Trial Kit. Precipitations of hcLeuRS, ⌬ChcLeuRS, and ChcLeuRS were confirmed by WB with anti-FLAG M2 antibody and anti-GFP antibody.
In Vitro Pull-down Assay-The sequence encoding the C-terminal 89 amino acids of hcLeuRS was amplified by PCR from the fj01313 clone with primers P17 and P2 then inserted into the gap between SalI and NotI sites of pET-22b (ϩ). The fragment between NcoI and XhoI was inserted into the pGEX-KG vector to obtain plasmid pGEX-KGChcleus. GST and GST-ChcLeuRS were produced from E. coli BL21-CodonPlus (DE3) transformants containing pGEX-KG and pGEX-KGChcleus. Cells were sonicated and centrifuged to get the supernatant. GST and GST-ChcLeuRS (1 g of each) were incubated separately with glutathione-Sepharose 4B for 40 min. After washing the Sepharose four times with phosphate-buffered saline, 1 g of hcArgRS and ⌬NhcArgRS each was diluted in binding buffer (20 mM HEPES, pH 7.5, 200 mM KCl, 5 mM MgCl 2 , 0.2% bovine serum albumin, 10% glycerol, 0.1% Nonidet P-40, 1 mM phenylmethylsulfonyl fluoride, and complete protease inhibitor mixture), added separately, and then the incubation was continued for 2 h. The Sepharose was washed five times with binding buffer (without bovine serum albumin and glycerol), and bound proteins were eluted from the Sepharose by boiling in 1ϫ SDS loading buffer. The presence of hcArgRS and ⌬NhcArgRS was detected using WB with anti-ArgRS antibody and horseradish peroxidase-conjugated secondary antibody. (23, 24, 27) . In most cases, the recombinant proteins are processed and targeted to their appropriate subcellular locations (23, 24, 27) . The cytosol and mitochondria of Tn5 insect cells infected by baculovirus containing hcleus and ⌬Chcleus were separated, and the subcellular fraction quality was controlled by the activity determination of the marker enzyme succinate dehydrogenase (TABLE TWO) (23) (24) (25) . Succinate dehydrogenase activity is high in mitochondria but is not present in cytosol. The present data showed that the fractions were well separated; in the cytosol, there was no contamination of mitochondria where the gene encoding LeuRS was different from that in cytosol (23) . From the cytoplasm of 2 ϫ 10 8 insect cells, about 250 g of hcLeuRS and 600 g of ⌬ChcLeuRS was obtained through an Ni 2ϩ -NTA column. The proteins were of 90% homogeneity with 135-and 125-kDa molecular masses as determined by SDS-PAGE (Fig. 2) . The molecular masses are close to the theoretical values determined from the cDNA sequence. We also sequenced the N terminus of hcLeuRS with protein sequencer 477A as performed previously on hmLeuRS (23) . Sequencing results indicated that the N terminus of hcLeuRS expressed in the insect cells is blocked.
RESULTS

Functional Expression and Purification of hcLeuRS and ⌬ChcLeuRS-Recombinant baculovirus vectors have been widely used to express heterologous genes in cultured insect cells
Similar Activity, Kinetic Constants, and Thermal Stability of hcLeuRS and ⌬ChcLeuRS-For the activity determination of hcLeuRS and ⌬ChcLeuRS, the concentration of magnesium and the pH value were optimized to 2 mM and 7.6, respectively. 
Kinetic constants of hcLeuRS and ⌬ChcLeuRS at 37°C
The experiments were performed as described under "Experimental Procedures." S.E. values were determined from three independent data sets. 
Substrates Constants hcLeuRS ⌬ChcLeuRS
ATP-PP
Kinetic constants of hcArgRS and ⌬NhcArgRS at 37°C
The experiments were performed as described under "Experimental Procedures." S.E. values were determined from three independent data sets.
Substrates Constants hcArgRS ⌬NhcArgRS
ATP-PP i exchange Arginylation ATP-PP i exchange Arginylation
Arginine (23) . It is reasonable that hcLeuRS catalyzes leucylation of tRNA Leu more quickly than hmLeuRS, because human mitochondria translation machinery synthesizes only 13 peptides, a number much less than that in the cytosol (32) .
The specific activity of ⌬ChcLeuRS is identical to that of hcLeuRS in the ATP-PP i exchange reaction but about 2-fold that of hcLeuRS in the leucylation of the tRNA reaction. Although in the aminoacylation reaction, the K m values of ⌬ChcLeuRS for leucine, ATP, calf liver tRNA Leu , and transcripts of hctRNA Leu were almost the same as those of hcLeuRS, the k cat values were 1-fold greater than those of hcLeuRS, indicating that the C terminus does not impair the binding of these three substrates or the activity of the enzyme.
Under our experimental conditions, both hcLeuRS and ⌬ChcLeuRS were thermostable below 37°C; however, both lost their activity completely when incubated above 50°C. Both thermal inactivation curves had no obvious differences (data not shown), indicating that the removal of the C terminus from hcLeuRS does not affect thermal stability.
Kinetic Constants of hcArgRS and ⌬NhcArgRS (TABLE FOUR)-
The K m values of both hcArgRSs in amino acid activation and aminoacylation reactions are similar; however, the k cat values of ⌬NhcArgRS are slightly higher than those of hcArgRS. If total tRNA from calf liver is used as the substrate, in amino acid activation reaction, the average k cat value of hcArgRS is 7.5 s Ϫ1 and that of ⌬NhcArgRS is 18.6 s Ϫ1 ; in the aminoacylation reaction, that of hcArgRS is 0.34 s Ϫ1 and that of ⌬NhcArgRS is 0.85 s Ϫ1 . The catalytic efficiency of hcArgRS and ⌬NhcArgRS in ATP-PP i exchange for calf liver tRNA is 1.2 ϫ 10 5 and 1.8 ϫ 10 5 s Ϫ1 mM Ϫ1 , respectively; that in aminoacylation is 780 and 2400
Subcellular Localizations of hcLeuRS, ⌬ChcLeuRS, hcArgRS, and ⌬NhcArgRS in Human Cells-To determine the subcellular localization of hcLeuRS, ⌬ChcLeuRS, hcArgRS, and ⌬NhcArgRS in human cells, 293 T cells were used to express the genes encoding hcLeuRS, ⌬ChcLeuRS, hcArgRS, and ⌬NhcArgRS fused with green fluorescence protein (EGFP tag). The green fluorescence of the C-terminal EGFPtagged hcLeuRS, ⌬ChcLeuRS, hcArgRS, and ⌬NhcArgRS was exclusively in the cytosol of 293 T cells (Fig. 3) . As a positive control, EGFP was observed in both nuclei and cytosol (Fig. 3) . Similar observations of the EGFP positive control were presented in other experiments (33, 34) . (35) , hcLeuRS possibly interacts with hcArgRS in the complex system.
C Terminus of hcLeuRS Binds N Terminus of hcArgRS-Since previous investigation indicated that hcLeuRS is adjacent to hcArgRS in human aaRS complex
To test the possibility of hcLeuRS binding to hcArgRS, the 293 T cells were transiently transfected with pCDNA3-hcleus-flag and pCDNA3-⌬Chcleus-flag, respectively. Cell lysates were immunoprecipitated with monoclonal anti-FLAG M2 antibody, which would recognize the FLAG-tagged hcLeuRS and ⌬ChcLeuRS. Data of WB analysis with anti-ArgRS antibody showed that hcLeuRS transiently expressed in 293 T cells co-immunoprecipitated with the endogenetic hcArgRS, whereas ⌬ChcLeuRS did not (Fig. 4A) . These coimmunoprecipitation results indicate that hcLeuRS does interact with hcArgRS in vivo and that the responsible region of hcLeuRS lies in its C terminus.
To further elucidate the importance of the C-terminal region of hcLeuRS interacted with hcArgRS, the plasmid pEGFP-N2-Chcleus that expressed the EGFP-fused C-terminal 89 amino acid residues of hcLeuRS (ChcLeuRS-EGFP) was constructed and transfected into 293 T cells with a negative control of pEGFP-N2. If the C-terminal peptide of hcLeuRS alone had the ability of interacting with hcArgRS, the coeluted hcArgRS would be detectable by Western blot using the antiArgRS antibody. As shown in Fig. 4B , the transiently expressed ChcLeuRS-EGFP was co-immunoprecipitated with the endogenetic hcArgRS, indicating that even an isolated C-terminal peptide of hcLeuRS can interact with hcArgRS.
There are two isoforms of hcArgRS in human cells (16) . The fulllength hcArgRS is the majority, and the ⌬NhcArgRS is the minority (Fig. 4) . From the molecular weight sizes shown in the two experiments above, hcLeuRS and ChcLeuRS clearly interact with the full-length hcArgRS. However, the possibility could not be excluded that hcLeuRS and ChcLeuRS can also bind ⌬NhcArgRS, because the nondetection of their interactions might result from the trace quantity of endogenetic ⌬NhcArgRS.
To clarify the responsible region in hcArgRS for interacting with ChcLeuRS, ChcLeuRS was expressed as a GST fusion form, and the purified hcArgRS and ⌬NhcArgRS were employed in the in vitro pulldown assay. The results clearly showed that only hcArgRS was co-eluted with ChcLeuRS; ⌬NhcArgRS was not (Fig. 5) . These data indicate that the responsible domain in hcArgRS interacted with ChcLeuRS is its N-terminal motif.
Therefore, the conclusion can be drawn that the C-terminal peptide of hcLeuRS is critical for the interaction with hcArgRS, and the interaction is exactly through the N-terminal extension of hcArgRS and not the catalytic domain.
DISCUSSION
In the present investigation, the free form of hcLeuRS was first purified through cloning followed by the expression of hcLeuRS cDNA in insect cells. The molecular mass, kinetic properties, thermal stability, and subcellular localization of hcLeuRS are reported. These results confirm that the cDNA isolated from human fetal brain encodes hcLeuRS. Previously, LeuRS has been isolated from the sheep liver multienzyme complex (10) that has a specific activity of 314 units/mg at 25°C. Thus, purified hcLeuRS in the present study is quite active (125 units/mg) even when it is not associated with other components of the complex. This indicates that the complex formation is not essential for the activity of hcLeuRS. Similar conditions were found in human ArgRS (20, 21) , GlnRS (36), AspRS (37), LysRS (38, 39) , and MetRS (40) , which also have aminoacylation activity without assembling to the complex.
The C-terminal of hcLeuRS is dispensable for enzymatic activity. This phenomenon is common in mammalian aaRSs. The N-terminal truncated rat AspRS is also fully active but less stable (41) . Likewise, human TyrRS and AspRS do not need their N-terminal extension to express activity (42) (43) (44) . The C terminus of human IleRS is also dispensable for the detection of aminoacylation activity (45) . The N terminus of human ArgRS is not required for enzyme activity (20) . However, human GlnRS N-terminal is required for enzymatic activity (36) . Terminal appendices of some cytosolic aaRSs in higher eukaryotes serve as cis-acting tRNA-interacting factors (tIFs), which provide the core enzymes with potent tRNA-binding capacity, such as human LysRS (39), MetRS (40), HisRS (46) , and Bombys mori GlyRS (47) . Currently available data do not suggest any biological rules concerning these phenomena.
The catalytic efficiency of hcLeuRS and ⌬ChcLeuRS for tRNA Leu s from either calf liver total tRNA or transcripts of tRNA Leu is low. One reason for low catalytic efficiency could be that noncognate tRNAs in calf liver total tRNA inhibited the activity of hcLeuRSs. A second reason may be that transcripts of tRNA Leu without modified bases decreased the charge level by hcLeuRSs. A third reason is probably that hcLeuRSs purified from insect cells by multisteps partially lost their activities and could not reach the highest charging activities of tRNA Leu . Although the catalytic efficiency of hcArgRS and ⌬NhcArgRS for calf liver total tRNA FIGURE 5. C terminus of hcLeuRS interacts with N terminus of hcArgRS. Top, the GST-ChcLeuRS fusion protein binding to glutathione-Sepharose was incubated with hcArgRS and ⌬NhcArgRS, respectively. After elution of GST-ChcLeuRS with binding proteins, hcArgRS and ⌬NhcArgRS were detected using WB analysis with anti-ArgRS antibody. The right two bands are purified hcArgRS and ⌬NhcArgRS immunoblotted as molecular weight markers. Bottom, GST and GST-ChcLeuRS used as bait proteins in pulldown assays were examined on 10% SDS-PAGE by staining with Coomassie Brilliant Blue.
is comparable with that of reported hamster ArgRSs (21) (51) . We know that the addition of other protein factors increased the aminoacylation activities of some eukaryotic aaRSs. For example, the yeast GluRS apoenzyme fails to show significant kinetics of tRNA aminoacylation and charges unfractionated yeast tRNA at a level 10-fold reduced compared with Arc1p-bound GluRS (51); EF-1␣-GTP stimulated the activity of valyl-tRNA synthetase (52) . Whether the activities of hcLeuRS and hcArgRS depend upon other proteins is unclear in the present stage. hcLeuRS and hcArgRS were proposed to localize to nuclei and participate in the nuclear export of tRNA Leu (53) . However, in the present report, hcLeuRS and hcArgRS were not detected in nuclei by confocal fluorescence microscopy, an observation possibly due to the low quantity of hcLeuRS and hcArgRS in nuclei or to the different growth conditions of cells between the present and previous experiments (53) . The cellular conditions have been shown to affect in vivo subcellular distribution of human cytosolic aaRSs, as observed in the case of human cytosolic methionyl-tRNA synthetase (54) . Some experiments have been performed previously to detect interactions between the extension domains of aaRSs in the complex (15, 19, 55) . Only some of the results of these experiments were identical to those of chemical cross-linking (15) , suggesting that the catalytic domains of some aaRSs are also required for the maintenance of the complex. Previous work also has proved that the catalytic domain of human GlnRS, not the appended domain, is necessary for its assembly to the complex (36) . In contrast, the present work indicated that hcLeuRS interacts with hcArgRS, another component in the complex, only through its appended domain. The interaction network of the multisynthetase complex is thus composed of not only terminal interactions but also interactions among catalytic domains, and this network links the components of the complex together to keep them a whole.
Electron microscopic images have shown that the multisynthetase complex presents an elongated U-shape with three subdomains (35) . In this particular model, LeuRS is located in the subdomain III and is adjacent to ArgRS and p43 (35) . The results presented here indicate that the interaction between hcLeuRS and hcArgRS through the terminal extension domain is essential and sufficient for hcLeuRS to incorporate into the complex. Since p38 has been suggested as the scaffold protein of the complex (14, 18) , p43 binds the p38 leucine zipper motif with its N-terminal domain (56) , and p38, p43, GlnRS, and ArgRS probably form a stable subcomplex (18) ; therefore, the dissociation of hcLeuRS without a C-terminal appendix from the complex is reasonable. The N-terminal extension of hcArgRS is essential for its assembly into the multi-tRNA synthetase complex but has no effect on its catalytic activity (20, 21) . Our results show that the appendix of hcLeuRS is also a structural motif just like that of hcArgRS.
Although terminal extensions of many aaRSs in the complex have been shown to be dispensable for enzyme activities and stabilities and thus responsible for the enzyme-enzyme interactions, we must recognize that the terminal extension domains also exist in those aaRSs that do not form a complex (57, 58) . Therefore, it is likely that the terminal extension has some other function besides assembly. More experiments are needed to further elucidate any additional functions.
